SCHEMBL14291322

SCHEMBL14291322

O=C(Nc1cnc2ccccc2n1)Oc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.60
HSP90AA1 P07900 1/20 0.60
HSP90AB1 P08238 1/20 0.60
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
PDGFRB P09619 1/20 0.49
PDGFRA P16234 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 6/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CCNE1 P24864 1/20 0.46
CDK2 P24941 1/20 0.46
CDK5 Q00535 1/20 0.46
MAPT P10636 1/20 0.45
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22410707 0.89 KDM4E (0.55) KDM4EHSP90AA1HSP90AB1NPC1RAB9A
SCHEMBL15140307 0.83 KDM4E (0.71) KDM4EHSP90AA1HSP90AB1NPC1RAB9A
SCHEMBL8489674 0.80 NPC1 (0.60) NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL15726198 0.80 KMT2A (0.45) KDM4EHSP90AA1HSP90AB1NPC1RAB9A
SCHEMBL2595570 0.77 CCNE1 (0.47) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL14658243 0.77 NOTUM (0.51) KDM4EALDH1A1CCNE1CDK2CDK5
SCHEMBL7244914 0.77 ALDH1A1 (0.56) KDM4ERAB9ASMN1; SMN2ALDH1A1CCNE1
SCHEMBL4108874 0.77 KDR (0.63) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL305046 0.76 NOTUM (0.52) KDM4ESMN1; SMN2ALDH1A1HSD17B10CCNE1
SCHEMBL32672056 0.76 NOTUM (0.52) KDM4ESMN1; SMN2ALDH1A1HSD17B10CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008015423-A1 QUINOLINE AND QUINOXALINE N-OXIDES AS CHK-1 INHIBITORS SENTINEL ONCOLOGY LIMITED (GB) 2008-02-07 WO disclosed